Two decades (1998 to 2018) of collaborative human immunodeficiency virus clinical pharmacology capacity building in a resource constrained setting
- PMID: 34758831
- PMCID: PMC8579570
- DOI: 10.1186/s12962-021-00327-y
Two decades (1998 to 2018) of collaborative human immunodeficiency virus clinical pharmacology capacity building in a resource constrained setting
Abstract
While important advances have been made in the prevention and treatment of Human Immunodeficiency Virus (HIV) infection, limited expertise and resource constraints to effectively manage rollout of HIV programs often contribute to poor treatment outcomes in Sub-Saharan Africa. In 1998, the University of Zimbabwe (UZ) and the University at Buffalo, State University of New York (UB), developed a collaborative clinical pharmacology capacity building program in Zimbabwe to train the next generation of HIV researchers and support rollout of the national HIV program. The collaboration was funded by research and training grants that were competitively acquired through United States of America government funding mechanisms, between 1998 and 2016. Thirty-eight research fellows were trained and a specialty clinical pharmacology laboratory was established during this period. Knowledge and skills transfer were achieved through faculty and student exchange visits. Scientific dissemination output included sixty-two scholarly publications that influenced three national policies and provided development of guidelines for strategic leadership for an HIV infection-patient adherence support group. The clinical pharmacology capacity building program trained fellows that were subsequently incorporated into the national technical working group at the Ministry of Health and Child Care, who are responsible for optimizing HIV treatment guidelines in Zimbabwe. Despite serious economic challenges, consistent collaboration between UZ and UB strengthened UZ faculty scholarly capacity, retention of HIV clinical research workforce was achieved, and the program made additional contributions toward optimization of antiretroviral therapy in Zimbabwe.
Keywords: Capacity building; Clinical pharmacology; Collaboration; HIV; Research; Resource-limited.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- Maponga CC, Ma Q, Slish JC, Morse GD. HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries. Top Antivir Med. 2007;5:104–110. - PubMed
-
- World Health Organization. Taking stock: Health worker shortages and the response to AIDS. Strength Health Serv Fight HIV/AIDS. 2006;5:8–10.
-
- World Health Organisation. Zimbabwe Summary Country Profile For HIV/AIDS Treatment Scale-Up December 2005. https://www.who.int/hiv/HIVCP_ZWE.pdf
Publication types
Grants and funding
- D43TW007991/TW/FIC NIH HHS/United States
- UM1AI106701/National Institute of Allergy and Infectious Diseases
- P30AI078498/Center for AIDS Research, University of Rochester Medical Center
- D43TW00799101A2S1/TW/FIC NIH HHS/United States
- UL1 TR001412/TR/NCATS NIH HHS/United States
- SA5335-32119/TW/FIC NIH HHS/United States
- UM1AI068636/National Institute of Allergy and Infectious Diseases
- AI068634/National Institute of Allergy and Infectious Diseases
- UL1TR001412/TR/NCATS NIH HHS/United States
- HHSN272201500006C/AI/NIAID NIH HHS/United States
- R01 DA015024/DA/NIDA NIH HHS/United States
- D43TW010313/TW/FIC NIH HHS/United States
- P30 AI078498/AI/NIAID NIH HHS/United States
- R01DA015024-03S2/DA/NIDA NIH HHS/United States
- HHSN272200800019C/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
